MedPath

RLE Outcomes With Bilateral Implantation of Odyssey IOLs

Recruiting
Conditions
Refractive Lens Exchange
Registration Number
NCT06979557
Lead Sponsor
Mann Eye Institute
Brief Summary

This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as measurement of visual acuities at distance, intermediate, and near, monocular (right eye) and binocular defocus curve, and refractive outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Participants will include 40 patients aged 40 years and older who have a measurable Potential Acuity Meter (PAM) of 20/20 electing to undergo bilateral refractive lensectomy surgery with IOL implantation.
Exclusion Criteria
  • Patients with significant ocular comorbidities (e.g., macular degeneration, glaucoma) or prior intraocular surgery will be excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Binocular Photopic Visual Acuity2 months posoperatively

Measured at distance (6m), intermediate at 66cm, and near visual acuity at 40cm and 33cm.

Monocular Photopic Visual Acuity2 months posoperatively

Measured at distance (6m), intermediate at 66cm, and near visual acuity at 40cm and 33cm.

Monocular Defocus Curve (right eye only)2 months posoperatively
Binocular Defocus Curve2 months posoperatively
Secondary Outcome Measures
NameTimeMethod
Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) Questionnaire2 months posoperatively

The AIOLIS has 37 questions about symptoms, perceptions of general vision, and frequency of wearing glasses or contact lenses. Lower scores for the symptom questions indicate lower frequency and both of visual disturbances.

Trial Locations

Locations (1)

Mann Eye Institute

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath